95
Participants
Start Date
January 30, 2015
Primary Completion Date
December 13, 2018
Study Completion Date
March 8, 2023
Adavosertib
Adavosertib will be taken as oral capsules with water, approx. 2 hours before or 2 hours after food.
Paclitaxel
"Paclitaxel will be administered as a 1-hour IV infusion (± 10 minutes) at a dose of 80 mg/m2 according to institutional standards on Days 1, 8, and 15 of each 28 Day cycle.~Patients should be pre-medicated with corticosteroids, diphenhydramine and/or H2 antagonists according to institutional standards."
Carboplatin
Carboplatin, at a dose calculated to produce an AUC of 5 will be administered by intravenous infusion according to institutional standards on Day 1 of each 21 Day cycle. The carboplatin dose will be calculated using the Calvert Formula based on the patient's glomerular filtration rate (GFR) which is estimated by using the creatinine clearance.
Gemcitabine
Gemcitabine 800 mg/m² will be administered IV on Days 1, 8, and 15 of each 28-Day cycle.
PLD
PLD (pegylated liposomal doxorubicin) 40 mg/m² IV will be given on Day 1 of each 28-Day cycle.
Research Site, New York
Research Site, New York
Research Site, Abington
Research Site, Augusta
Research Site, West Palm Beach
Research Site, Tampa
Research Site, Nashville
Research Site, Cleveland
Research Site, Detroit
Research Site, Milwaukee
Research Site, Oklahoma City
Research Site, Dallas
Research Site, Gilbert
Research Site, Tucson
Research Site, Los Angeles
Research Site, La Jolla
Research Site, San Francisco
Research Site, Boston
Research Site, Toronto
Research Site, Amsterdam
Lead Sponsor
AstraZeneca
INDUSTRY